Term ends Jul 25, 2028 · High confidence
20-year base term ends Jul 25, 2028
Held by JCR Pharmaceuticals Co., Ltd.
Filed Jan 27, 2015 as application 14/606,239 · Granted Feb 14, 2017
Base term, 20 years from filing
Today
2008
2028
Clock starts
Jul 25, 2008
Jul 25, 2008
Term ends
Jul 25, 2028
Jul 25, 2028
Granted
Feb 14, 2017
Feb 14, 2017
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,974,791, to Jul 25, 2028. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 25, 2008, when application 12/179,806, the earliest non-provisional in its chain, was filed (this one was filed Jan 27, 2015) | Jul 25, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,974,791) | resolves to Jul 25, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 25, 2028 | High confidence |
This family
| US 8,974,791 | In force Jul 2028 | Jul 2028 |
| US 9,567,400 | this patent Jul 2028 | Jul 2028 |
| US 10,202,467 | In force Jul 2028 | Jul 2028 |
| US 11,512,145 | In force Jul 2028 | Jul 2028 |
| Application 18/048,000 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 5, 2015 Reel 35842, frame 374 | Pardridge, William M.; Boado, Ruben J. | Armagen Technologies, Inc. | Assignment of Assignor's Interest |
| Feb 2, 2018 Reel 44815, frame 135 | Armagen, Inc. | Oxford Finance LLC, as Collateral Agent and Lender | Security Interest |
| Nov 18, 2019 Reel 51042, frame 528 | Oxford Finance LLC | JCR Pharmaceuticals Co., Ltd. | Assignment of Assignor's Interest |
| Apr 11, 2020 Reel 52373, frame 585 | JCR Pharmaceuticals Co., Ltd. | Armagen, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jul 2028
Term ends Jul 25, 2028. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,974,791, ends no earlier than this term, so it caps nothing.
Citations
4
later US patents cite this one
That is below the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.